Stocks News

LAST PRICE
39.1200
TODAY'S CHANGE (%)
Trending Up2.6600 (7.2957%)

Bid / Lots
38.0000/ 1
Ask / Lots
50.0000/ 5
Open / Previous Close
36.1600 / 36.4600
Day Range
Low 35.6800
High 40.2000
52 Week Range
Low 25.6000
High 77.6000
Volume
438,355
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 30, 2024
- Disc Medicine to Participate in the Jefferies Global Healthcare Conference, from 9:00AM ET on Thursday May 30, 2024 by GlobeNewswire
  9:00AM ET on Thursday May 30, 2024 by GlobeNewswire
  Companies Mentioned: IRON
- Disc Medicine to Participate in the Jefferies Global Healthcare Conference, from 9:00AM ET on Thursday May 30, 2024 by Dow Jones
  9:00AM ET on Thursday May 30, 2024 by Dow Jones
  Companies Mentioned: IRON
  
  Disc Medicine to Participate in the Jefferies Global Healthcare Conference
  
  WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will give a corporate presentation at the Jefferies Global Healthcare Conference on Thursday, June 6(th) at 1:00 pm ET.
May 28, 2024
- DJ Disc Medicine Price Target Maintained With a $85.00/Share by Cantor Fitzgerald, from 9:52AM ET on Tuesday May 28, 2024 by Dow Jones
  9:52AM ET on Tuesday May 28, 2024 by Dow Jones
  Companies Mentioned: IRON
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IRON/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 28, 2024 09:52 ET (13:52 GMT)
May 15, 2024
- DJ Disc Medicine Price Target Maintained With a $85.00/Share by Cantor Fitzgerald, from 8:12AM ET on Wednesday May 15, 2024 by Dow Jones
  8:12AM ET on Wednesday May 15, 2024 by Dow Jones
  Companies Mentioned: IRON
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IRON/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 15, 2024 08:12 ET (12:12 GMT)
May 14, 2024
- Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress, from 10:30AM ET on Tuesday May 14, 2024 by GlobeNewswire
  10:30AM ET on Tuesday May 14, 2024 by GlobeNewswire
  Companies Mentioned: IRON

Today
- Claims Against ARS Pharmaceuticals, Inc.: Schall Law Firm Begins Probe And Invites Affected Investors To Connect, from 44 minutes ago by Accesswire
  44 minutes ago by Accesswire
  Companies Mentioned: SPRY
Yesterday
- Allegations Against ARS Pharmaceuticals, Inc.: Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Reach Out, from 1:02PM ET on Thursday Jun 06, 2024 by Accesswire
  1:02PM ET on Thursday Jun 06, 2024 by Accesswire
  Companies Mentioned: SPRY
Jun 5, 2024
- ARS Pharmaceuticals, Inc. Allegations: Schall Law Firm Commences Examination and Calls on Affected Investors to Connect, from 1:47PM ET on Wednesday Jun 05, 2024 by Accesswire
  1:47PM ET on Wednesday Jun 05, 2024 by Accesswire
  Companies Mentioned: SPRY
Jun 4, 2024
- The Schall Law Firm is commencing an examination into allegations against ARS Pharmaceuticals, Inc. and is calling on investors who have experienced losses to get in touch, from 3:50PM ET on Tuesday Jun 04, 2024 by Accesswire
  3:50PM ET on Tuesday Jun 04, 2024 by Accesswire
  Companies Mentioned: SPRY
Jun 3, 2024
- SPRY INVESTIGATION PROGRESS REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 7:31PM ET on Monday Jun 03, 2024 by Accesswire
  7:31PM ET on Monday Jun 03, 2024 by Accesswire
  Companies Mentioned: SPRY
- Humacyte Insider Sold Shares Worth $1,561,605, According to a Recent SEC Filing, from 4:26PM ET on Monday Jun 03, 2024 by MT Newswires
  4:26PM ET on Monday Jun 03, 2024 by MT Newswires
  Companies Mentioned: HUMA
Jun 2, 2024
- IMPORTANT INVESTIGATION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:08AM ET on Sunday Jun 02, 2024 by Accesswire
  11:08AM ET on Sunday Jun 02, 2024 by Accesswire
  Companies Mentioned: SPRY
Jun 1, 2024
- IMPORTANT INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:09AM ET on Saturday Jun 01, 2024 by Accesswire
  11:09AM ET on Saturday Jun 01, 2024 by Accesswire
  Companies Mentioned: SPRY
May 31, 2024
- IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 6:06PM ET on Friday May 31, 2024 by Accesswire
  6:06PM ET on Friday May 31, 2024 by Accesswire
  Companies Mentioned: SPRY
May 30, 2024
- IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 2:16PM ET on Thursday May 30, 2024 by Accesswire
  2:16PM ET on Thursday May 30, 2024 by Accesswire
  Companies Mentioned: SPRY

Disc Medicine Inc
NASDAQ:IRONUnited States

Search Criteria

May 30, 2024

Disc Medicine to Participate in the Jefferies Global Healthcare Conference, from 9:00AM ET on Thursday May 30, 2024 by GlobeNewswire

Disc Medicine to Participate in the Jefferies Global Healthcare Conference, from 9:00AM ET on Thursday May 30, 2024 by Dow Jones

May 28, 2024

DJ Disc Medicine Price Target Maintained With a $85.00/Share by Cantor Fitzgerald, from 9:52AM ET on Tuesday May 28, 2024 by Dow Jones

May 15, 2024

DJ Disc Medicine Price Target Maintained With a $85.00/Share by Cantor Fitzgerald, from 8:12AM ET on Wednesday May 15, 2024 by Dow Jones

May 14, 2024

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress, from 10:30AM ET on Tuesday May 14, 2024 by GlobeNewswire

Peers Headlines

Today

Claims Against ARS Pharmaceuticals, Inc.: Schall Law Firm Begins Probe And Invites Affected Investors To Connect, from 44 minutes ago by Accesswire

Yesterday

Allegations Against ARS Pharmaceuticals, Inc.: Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Reach Out, from 1:02PM ET on Thursday Jun 06, 2024 by Accesswire

Jun 5, 2024

ARS Pharmaceuticals, Inc. Allegations: Schall Law Firm Commences Examination and Calls on Affected Investors to Connect, from 1:47PM ET on Wednesday Jun 05, 2024 by Accesswire

Jun 4, 2024

The Schall Law Firm is commencing an examination into allegations against ARS Pharmaceuticals, Inc. and is calling on investors who have experienced losses to get in touch, from 3:50PM ET on Tuesday Jun 04, 2024 by Accesswire

Jun 3, 2024

SPRY INVESTIGATION PROGRESS REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 7:31PM ET on Monday Jun 03, 2024 by Accesswire

Humacyte Insider Sold Shares Worth $1,561,605, According to a Recent SEC Filing, from 4:26PM ET on Monday Jun 03, 2024 by MT Newswires

Jun 2, 2024

IMPORTANT INVESTIGATION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:08AM ET on Sunday Jun 02, 2024 by Accesswire

Jun 1, 2024

IMPORTANT INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:09AM ET on Saturday Jun 01, 2024 by Accesswire

May 31, 2024

IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 6:06PM ET on Friday May 31, 2024 by Accesswire

May 30, 2024

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 2:16PM ET on Thursday May 30, 2024 by Accesswire